Skip to Main Content

News

August Policy Update

Fecha: 23/06/22

Thank you for your continued partnership with Ambetter. As you know, we continually review and update our payment and utilization policies to ensure that they are designed to comply with industry standards while delivering the best patient experience to our members. We are writing today to inform you of new policies Ambetter will be implementing effective 8/1/2022.

Policy Number

Policy Name

Policy Description

Lines of Business

CP.MP.209

Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing

Restricts reimbursement of GI pathogen panels with 12+ targets to only inpatient settings, including inpatient, ED, and outpatient hospitals.

Marketplace

For detailed information about these policies, please refer to our website at www.ambettermeridian.com. And for questions about this or any of our payment policies, please don’t hesitate to reach out to our Provider Services team at 833-993-2426.